352003 <common-name>N-[5-(anilinomethyl)-3-(2-methoxyphenyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl]-4-[(2-chlorophenyl)methylideneamino]benzamide</common-name> <description>N-[5-(anilinomethyl)-3-(2-methoxyphenyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl]-4-[(2-chlorophenyl)methylideneamino]benzamide is a chemical compound with the formula C32H26ClN5O4S. With an average molecular weight of 612.10 g/mol, N-[5-(anilinomethyl)-3-(2-methoxyphenyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl]-4-[(2-chlorophenyl)methylideneamino]benzamide is a heavy molecule.</description> <cas>131528-75-1</cas> <pubchem-id>3076511</pubchem-id> <chemical-formula>C32H26ClN5O4S</chemical-formula> <weight>612.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T18:04:48Z</created-at> <updated-at type="dateTime">2026-08-31T18:04:48Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=CC=CC=C1N2C(=O)C(C(=O)N(C2=S)NC(=O)C3=CC=C(C=C3)N=CC4=CC=CC=C4Cl)CNC5=CC=CC=C5</moldb-smiles> <moldb-formula>C32H26ClN5O4S</moldb-formula> <moldb-inchi>InChI=1S/C32H26ClN5O4S/c1-42-28-14-8-7-13-27(28)37-30(40)25(20-35-23-10-3-2-4-11-23)31(41)38(32(37)43)36-29(39)21-15-17-24(18-16-21)34-19-22-9-5-6-12-26(22)33/h2-19,25,35H,20H2,1H3,(H,36,39)</moldb-inchi> <moldb-inchikey>CCIKNZXXJZOYAM-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">611.1394032</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM347896</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[5-(anilinomethyl)-3-(2-methoxyphenyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-1-yl]-4-[(2-chlorophenyl)methylideneamino]benzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0302293</sync-id> <structure-inchikey>CCIKNZXXJZOYAM-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000020000800040000000000000000000000100200000000000400000000200040021800000000002000004000000000000404000000002000000000000000000400000000000000000000020100000000301000104000000000000000000010020000040000080008000000400000100000840020000001000110000000040000000800000000000000080000000021100000002000000000000000100001000000002000000084000002080000000000000000000000000000080000000000004000802000000010000400012004000040000000200000000000000000000000002000040000000000400001000000020000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAArAAAALwAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkAoAAAAAwQHACgAAAADAwYAKAAAAAMECAAoAAAAAwIGAGAAAAADAQYAKAAA AAMECAAoAAAAAwIHACgAAAADAwYAKAAAAAMEEAAoAAAAAwIHAGgAAAADAgEG ACgAAAADBAgAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQcAKAAAAAMDBgBoAAAAAwMBBkAoAAAA AwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BBEAIAAAAAEGAGAAAAACAgcAaAAAAAMCAQZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBCwABAAECIAIDaAwD BGgMBAVoDAUGaAwGB2gMBwggCAkgCQooAgkLAAsMAAwNKAIMDiAODyAPECgC DhEAERIgEhMoAhIUIBQVaAwVFmgMFhdoDBcYaAwYGWgMFxogGhsoAhscIBwd aAwdHmgMHh9oDB8gaAwgIWgMISIACyMAIyQAJCUgJSZoDCYnaAwnKGgMKClo DCkqaAwHAmgMDwggGRRoDCEcaAwqJWgMQgUAAAAGAgcGBQQDBgkLDA4PCAYV FhcYGRQGHR4fICEcBiYnKCkqJRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:49:50Z</structure-indexed-at> </compound>